Nexlizet, a two-in-one cholesterol tablet, is now registered in Australia
What’s changed The Therapeutic Goods Administration (TGA) has approved Nexlizet, a single tablet combining two established cholesterol-lowering medicines: 180 mg of bempedoic acid and 10 mg of ezetimibe. The TGA made its decision on 17 September 2026, and the medicine










